Transitional Cell Carcinoma of the Ureter: Prognostic Factors Influencing Progression and Survival

European Urology

Volumn 51, Issue 5, 2007, Pages 1281-1288

  Lehmann, Jan ^a   Suttmann, Henrik ^a   Kovač, Iva ^a   Hack, Markus ^a   Kamradt, Jörn ^a   Siemer, Stefan ^a   Wullich, Bernd ^a   Zwergel, Ulrike ^a   Stöckle, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Prognostic factors; Transitional cell carcinoma; Upper urinary tract tumour; Ureter; Urothelial cancer

Indexed keywords

ALKALINE PHOSPHATASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMINEPHRECTOMY; HIGH RISK PATIENT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; TRANSITIONAL CELL CARCINOMA; UREA NITROGEN BLOOD LEVEL; URETER CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; PROGNOSIS; URETER; URETERAL NEOPLASMS;

EID: 33947215430     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.11.021     Document Type: Article

References (22)

1. Hall M.C., Womack S., Sagalowsky A.I., et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52 (1998) 594-601
2. Babaian R.J., and Johnson D.E. Primary carcinoma of the ureter. J Urol 123 (1980) 357-359
3. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
4. Oosterlinck W., Solsona E., van der Meijden A.P., et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 46 (2004) 147-154
5. Hurle R., Losa A., Manzetti A., et al. Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patients. Urology 53 (1999) 1144-1148
6. Kakizoe T., Fujita J., Murase T., et al. Transitional cell carcinoma of the bladder in patients with renal pelvic and ureteral cancer. J Urol 124 (1980) 17-19
7. Krogh J., Kvist E., and Rye B. Transitional cell carcinoma of the upper urinary tract: prognostic variables and post-operative recurrences. Br J Urol 67 (1991) 32-36
8. Kang C.H., Yu T.J., Hsieh H.H., et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98 (2003) 1620-1626
9. Park S., Hong B., Kim C.S., et al. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol 171 (2004) 621-625
10. Sobin LH, Fleming ID. TNM classification of malignant tumors. 5th ed. (1997) Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803-4.
11. Lehmann J., Retz M., Nürnberg N., et al. The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinoma. Cancer 101 (2004) 1552-1562
12. Batata M.A., Whitmore W.F., Hilaris B.S., et al. Primary carcinoma of the ureter: a prognostic study. Cancer 35 (1975) 1626-1632
13. Anderstrom C., Johansson S.L., Pettersson S., et al. Carcinoma of the ureter: a clinicopathologic study of 49 cases. J Urol 142 (1989) 280-283
14. Zungri E., Chechile G., Algaba F., et al. Treatment of transitional cell carcinoma of the ureter: is the controversy justified?. Eur Urol 17 (1990) 276-280
15. Henson D.E., Fielding L.P., Grignon D.J., et al. College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors Summary. Members of the Cancer Committee. Arch Pathol Lab Med 119 (1995) 1109-1112
16. Stauffer M. Nephrogenic hepatoslenomegaly. Gastroenterology 40 (1961) 694-700
17. Jorgensen T., Kanagasingam Y., Kaalhus O., et al. Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2. J Urol 158 (1997) 164-170
18. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
19. Di Carlo E., Forni G., and Musiani P. Neutrophils in the antitumoral immune response. In: Cassatella M.A. (Ed). The neutrophil (2003), Karger, Basel 182-203
20. Lee S.E., Byun S.S., Park Y.H., et al. Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract. Urol Int 77 (2006) 22-26
21. Kwak C., Lee S.E., Jeong I.G., et al. Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 68 (2006) 53-57
22. Czito B., Zietman A., Kaufman D., et al. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol 172 (2004) 1271-1275